 |
Articles: General Pharma |
Allos Therapeutics Announces Issuance of U.S. Patent for FOLOTYN
Allos Therapeutics, 12/01/09
Free full text
New Class of Platinum-Based Anti-Tumor Drugs, Bisplatinates, Demonstrates Potent Anti-Tumor Activity and Ability to Overcome Resistance to Currently Available Platinum-Based Agents
Cell Therapeutics, 12/01/09
Free full text
Multaq Approved in the European Union for Patients with Atrial Fibrillation
Sanofi-aventis, 12/01/09
Free full text
FDA drug approval intervals from 1997 to 2006: analysis and comparison during information technology implementation
International Journal of Electronic Healthcare, 12/01/09 FDA Grants Orphan Drug Designation for 3,4-DAP for LEMS
BioMarin, 12/01/09
Free full text
Bayer Starts Phase III Trial with Florbetaben
BayNews International, 12/01/09
Free full text
Bioequivalence of two film-coated tablets of imatinib mesylate 400 mg: A randomized, open-label, single-dose, fasting, two-period, two-sequence crossover comparison in healthy male South American volunteers
Clinical Therapeutics, 12/01/09 GlaxoSmithKline announced as Tier 3 Sponsor as London 2012 anti-doping plans confirmed
GlaxoSmithKline, 12/01/09
Free full text
Directly observed antiretroviral therapy: a systematic review and meta-analysis of randomised clinical trials
The Lancet - Early Online Publication, 12/01/09 Regulatory Update: GSK files Rotarix for prevention of rotavirus in Japan
GlaxoSmithKline, 12/01/09
Free full text
Cytokinetics to Present Non-Clinical Data Relating to CK-2017357 at the 5th Cachexia Conference
Cytokinetics, 12/01/09
Free full text
Cytokinetics Announces Clinical Trial Data Regarding SB-743921 to be Presented at the 2009 American Society of Hematology Annual Meeting and Exposition
Cytokinetics, 12/01/09
Free full text
Amgen Highlights Data to be Presented at ASH
Amgen, 12/01/09
Free full text
Prior Articles
Novartis gains rights to two oral targeted investigational therapies focusing on patients with life-threatening blood disorders and cancers
Novartis, 11/30/09
Free full text
Multitec Flex polyurethane spray system from BaySystems proves effective in theater: Long-lasting protection for stage sets
BayNews International, 11/30/09
Free full text
Diabetes experts underline benefits of SMBG for all types of treatment plans
BayNews International, 11/30/09
Free full text
Major European regulatory milestone in cardiovascular protection for Micardis : Now approved by the European Commission to reduce the risk of cardiovascular (CV) morbidity in high CV risk patients
Boehringer Ingelheim, 11/30/09
Free full text
Human genome sciences submits biologics license application to fda for zalbin
Human Genome Sciences, 11/30/09
Free full text
Lundbeck initiates clinical phase II trials with Lu AE58054 as augmentation treatment in Alzheimer's disease
Lundbeck, 11/30/09
Free full text
Development of biomaterial scaffold for nerve tissue engineering: Biomaterial mediated neural regeneration
BMC: Journal of Biomedical Science, 11/30/09
|
|
Receive free subspecialty "5-minute updates" via email
|
|
Indexed Journals: U.S.Pharmacist, FDA Drug Alerts, Pharmiweb
more...
|
250 Available Pages
|
|
